Is Apollo Hospitals overvalued or undervalued?

As of 5 September 2025, Apollo Hospitals' valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key financial ratios include a PE ratio of 71.31, an EV to EBITDA of 36.66, and a ROE of 17.61%.
In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while Max Healthcare and Fortis Healthcare are deemed very expensive with PE ratios of 94.34 and 77.45, respectively. Additionally, Apollo has demonstrated strong performance, with a year-to-date return of 7.00%, significantly outperforming the Sensex's 3.29% during the same period.